Yale University

Publications

Filters: Keyword is Reverse Transcriptase Inhibitors  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Y
Yang, Guangwei, Elijah Paintsil, Ginger E. Dutschman, Susan P. Grill, Chuan-Jen Wang, Jimin Wang, Hiromichi Tanaka, Takayuki Hamasaki, Masanori Baba, and Yung-Chi Cheng. "Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile." Antimicrobial agents and chemotherapy 53, no. 11 (2009): 4640-6. Abstract
S
Springer, Sandra A., Gerald H. Friedland, Gheorghe Doros, Edward Pesanti, and Frederick L. Altice. "Antiretroviral treatment regimen outcomes among HIV-infected prisoners." HIV clinical trials 8, no. 4 (2007): 205-12. Abstract
Springer, Sandra A., and Frederick L. Altice. "Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36, no. 12 (2003): e162-4. Abstract
R
del Rio, Carlos, and Gerald H. Friedland. "Report from the 12th Retrovirus Conference. HIV/AIDS in resource-limited settings." AIDS clinical care 17, no. 4 (2005): 39-40.
Raffanti, Stephen P., Jennifer S. Fusco, Beth H. Sherrill, Nellie I. Hansen, Amy C. Justice, Richard D'Aquila, Wendy J. Mangialardi, and Gregory P. Fusco. "Effect of persistent moderate viremia on disease progression during HIV therapy." Journal of acquired immune deficiency syndromes (1999) 37, no. 1 (2004): 1147-54. Abstract
M
Mugavero, Michael J., Margaret May, Ross Harris, Michael S. Saag, Dominique Costagliola, Matthias Egger, Andrew Phillips, Huldrych F. Günthard, Francois Dabis, Robert Hogg et al. "Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?" AIDS (London, England) 22, no. 18 (2008): 2481-92. Abstract
McCance-Katz, Elinore F., David E. Moody, Gene D. Morse, Gerald Friedland, Patricia Pade, Jennifer Baker, Anika Alvanzo, Patrick Smith, Abayomi Ogundele, Peter Jatlow et al. "Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S224-34. Abstract
McCance-Katz, Elinore F., Petrie M. Rainey, Patrick Smith, Gene D. Morse, Gerald Friedland, Beth Boyarsky, Marc Gourevitch, and Peter Jatlow. "Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 15, no. 1 (2006): 23-34. Abstract
Mannheimer, Sharon B., Nicholas Wold, Edward M. Gardner, Edward E. Telzak, Katherine Huppler Hullsiek, Margaret Chesney, Albert W. Wu, Rodger D. MacArthur, John Matts, and Gerald Friedland. "Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 46, no. 6 (2008): 941-5. Abstract
L
Ledergerber, Bruno, Jens D. Lundgren, Sarah A. Walker, Caroline Sabin, Amy Justice, Peter Reiss, Cristina Mussini, Ferdinand Wit, Antonella d'Arminio Monforte, Rainer Weber et al. "Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes." Lancet 364, no. 9428 (2004): 51-62. Abstract
J
Justice, Amy C., Daniel S. Stein, Gregory P. Fusco, Beth H. Sherrill, Jennifer S. Fusco, Susan C. Danehower, Stephen L. Becker, Nellie I. Hansen, and Neil M. H. Graham. "Disease progression in HIV-infected patients treated with stavudine vs. zidovudine." Journal of clinical epidemiology 57, no. 1 (2004): 89-97. Abstract
G
Golub, Sarit A., Lisa Rosenthal, Daniel E. Cohen, and Kenneth H. Mayer. "Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection." AIDS and behavior 12, no. 6 (2008): 852-9. Abstract
Gardner, Edward M., Shweta Sharma, Grace Peng, Katherine Huppler Hullsiek, William J. Burman, Rodger D. MacArthur, Margaret Chesney, Edward E. Telzak, Gerald Friedland, and Sharon B. Mannheimer. "Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance." AIDS (London, England) 22, no. 1 (2008): 75-82. Abstract
F
Friedland, Gerald H.. "Top stories of 2008. Antiretroviral rollout--successes and challenges." AIDS clinical care 21, no. 1 (2009): 5. Abstract
Friedland, Gerald H., and Sonia G. Nagy. "Report from the 12th Retrovirus Conference. Adherence." AIDS clinical care 17, no. 4 (2005): 36.
Friedland, Gerald. "Top stories of 2004. Nevirapine and efavirenz: similar efficacy, different toxicities, and better separately than combined." AIDS clinical care 17, no. 1 (2005): 5.
C
Cassol, Edana, Taryn Page, Anisa Mosam, Gerald Friedland, Chris Jack, Umesh Lalloo, Joe Kopetka, Bruce Patterson, Tonya Esterhuizen, and Hoosen M. Coovadia. "Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8." The Journal of infectious diseases 191, no. 3 (2005): 324-32. Abstract
B
Braithwaite, Scott R., Michael J. Kozal, Chung Chou H. Chang, Mark S. Roberts, Shawn L. Fultz, Matthew Bidwell Goetz, Cynthia Gibert, Maria Rodriguez-Barradas, Larry Mole, and Amy C. Justice. "Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies." AIDS (London, England) 21, no. 12 (2007): 1579-89. Abstract